These mutations are known to increase the stability of the mutant proteins and also disrupt the native conformation of the p53 protein, resulting in the inability to recognize and bind the cognate p53 response elements, while suppressing wild-type p53 and other p53 family members3–5, and thus impairing tumour-suppressive function and promoting oncogenesis. The gene discussed is TP53; the disease is neoplasm.